ReviewNature reviews. Urology2025

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.

Daniel J Benedetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.